Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹1,730 Cr₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹1,730 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹1,730 Cr
Mar2025₹1,538 Cr
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2026 ₹1,730 Cr
12.43
Mar2025 ₹1,538 Cr
81.35
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹95,900.7 Cr -1.6% -4.8% -8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.6%

-4.8%

-8.4%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses